AMAVA Regenerative Medicine

AMAVA Regenerative Medicine operates in Peoria, Arizona, under the clinical direction of Aneta Arzumanova, MSN APRN FNP-C, providing regenerative medicine services with particular emphasis on peptide-based weight management and hormone optimization. The clinic serves patients throughout the northwest Phoenix metropolitan area with in-person consultations designed to assess metabolic health, body composition metrics, and hormone panel results before initiating treatment protocols. Arzumanova's background as a board-certified family nurse practitioner informs the clinic's approach to integrating weight loss interventions with broader wellness optimization strategies.

The clinic's peptide therapy program centers on two GLP-1 receptor agonists: semaglutide and tirzepatide. Semaglutide protocols at AMAVA typically begin with subcutaneous injections at 0.25 mg weekly, with dose escalation based on patient tolerance and weight loss response over 16-20 week cycles. Tirzepatide treatment follows a similar titration model, starting at 2.5 mg weekly and advancing to therapeutic doses that address both glucose-dependent insulinotropic polypeptide and GLP-1 pathways. Both peptides are prescribed following comprehensive metabolic assessments that include fasting glucose, hemoglobin A1c, lipid panels, and thyroid function tests. The clinic structures these programs with regular body composition analysis to track fat mass reduction and lean tissue preservation throughout treatment.

Aneta Arzumanova brings clinical experience in family practice to her regenerative medicine protocols, applying diagnostic skills to identify underlying metabolic dysfunction before prescribing peptide therapy. Her approach includes evaluating patients for hormonal imbalances that may impede weight loss, such as hypothyroidism, cortisol dysregulation, or sex hormone deficiencies. For appropriate candidates, AMAVA offers testosterone replacement therapy alongside peptide protocols, particularly for male patients experiencing concurrent hypogonadism and metabolic syndrome. Arzumanova's nurse practitioner training emphasizes patient education on injection technique, side effect management, and realistic timeline expectations for peptide-based weight reduction.

Patients at AMAVA Regenerative Medicine in Peoria undergo initial consultations that include medical history review, current medication assessment, and discussion of weight loss goals with specific target metrics. The clinic provides instruction on proper subcutaneous injection methods for home administration of semaglutide or tirzepatide, along with protocols for managing common side effects such as nausea or gastrointestinal changes during dose escalation phases. Follow-up appointments occur at four-week intervals during active treatment, with each visit including weight measurement, body composition scanning, and clinical assessment for adverse reactions. The practice also offers IV therapy services that some patients combine with peptide protocols to address micronutrient deficiencies or support energy levels during caloric restriction periods.

AMAVA's location in Peoria positions the clinic to serve residents of Sun City, Glendale, and surrounding northwest Valley communities seeking alternatives to traditional weight loss approaches. The practice operates on an in-person consultation model, requiring patients to visit the Peoria facility for initial assessments and ongoing monitoring rather than offering telehealth options. This structure allows Arzumanova to perform hands-on physical examinations and directly observe patient response to treatment adjustments. The clinic's focus on regenerative medicine extends beyond weight management to include hormone optimization strategies for patients experiencing age-related decline in vitality, with treatment plans that may incorporate peptide therapy, bioidentical hormone replacement, and nutritional IV infusions as complementary interventions.